Table of Contents
Advances in Endocrinology
Volume 2014 (2014), Article ID 714291, 6 pages
http://dx.doi.org/10.1155/2014/714291
Review Article

Measuring Quality in Thyroid Cancer Surgery

Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, 600 Highland Avenue, K4/704 CSC, Madison, WI 53792, USA

Received 16 February 2014; Accepted 8 May 2014; Published 22 May 2014

Academic Editor: Pere Berbel

Copyright © 2014 David F. Schneider and Rebecca S. Sippel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Google Scholar
  2. K. Y. Bilimoria, D. J. Bentrem, C. Y. Ko et al., “Extent of surgery affects survival for papillary thyroid cancer,” Annals of Surgery, vol. 246, no. 3, pp. 375–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. I. D. Hay, M. E. Hutchinson, T. Gonzalez-Losada et al., “Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period,” Surgery, vol. 144, no. 6, pp. 980–988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. L. Mazzaferri and R. L. Young, “Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients,” American Journal of Medicine, vol. 70, no. 3, pp. 511–518, 1981. View at Google Scholar · View at Scopus
  5. E. L. Mazzaferri, R. L. Young, and J. E. Oertel, “Papillary thyroid carcinoma: the impact of therapy in 576 patients,” Medicine, vol. 56, no. 3, pp. 171–196, 1977. View at Google Scholar · View at Scopus
  6. D. F. Schneider and H. Chen, “New developments in the diagnosis and treatment of thyroid cancer,” CA: A Cancer Journal for Clinicians, vol. 63, no. 6, pp. 373–394, 2013. View at Publisher · View at Google Scholar
  7. Institute of Medicine (U.S.) and CoQoHCiA, Crossing the Quality Chasm: A New Health System for the 21st Century, National Academies Press, Washington, DC, USA, 2001.
  8. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. I. D. Hay, E. J. Bergstralh, J. R. Goellner et al., “Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989,” Surgery, vol. 114, no. 6, pp. 1050–1058, 1993. View at Google Scholar · View at Scopus
  10. J. Jonklaas, N. J. Sarlis, D. Litofsky et al., “Outcomes of patients with differentiated thyroid carcinoma following initial therapy,” Thyroid, vol. 16, no. 12, pp. 1229–1242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. M. Barney, Y. J. Hitchcock, P. Sharma, D. C. Shrieve, and J. D. Tward, “Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer,” Head and Neck, vol. 33, no. 5, pp. 645–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. I. J. Nixon, I. Ganly, S. G. Patel et al., “Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy,” Surgery, vol. 151, no. 4, pp. 571–579, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. L. Mazzaferri, “What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)?” Oncology, vol. 23, no. 7, pp. 579–588, 2009. View at Google Scholar · View at Scopus
  14. J. P. Shah, T. R. Loree, D. Dharker, and E. W. Strong, “Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis,” American Journal of Surgery, vol. 166, no. 4, pp. 331–335, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Shaha, J. P. Shah, and T. R. Loree, “Low-risk differentiated thyroid cancer: the need for selective treatment,” Annals of Surgical Oncology, vol. 4, no. 4, pp. 328–333, 1997. View at Google Scholar
  16. A. I. Stavrakis, P. H. G. Ituarte, C. Y. Ko, and M. W. Yeh, “Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery,” Surgery, vol. 142, no. 6, pp. 887–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. G. Gourin, R. P. Tufano, A. A. Forastiere, W. M. Koch, T. M. Pawlik, and R. E. Bristow, “Volume-based trends in thyroid surgery,” Archives of Otolaryngology—Head and Neck Surgery, vol. 136, no. 12, pp. 1191–1198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Youngwirth, J. Benavidez, R. Sippel, and H. Chen, “Parathyroid hormone deficiency after total thyroidectomy: incidence and time,” Journal of Surgical Research, vol. 163, no. 1, pp. 69–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Duclos, J. Peix, C. Colin et al., “Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study,” British Medical Journal, vol. 344, Article ID d8041, 2012. View at Google Scholar · View at Scopus
  20. B. D. Saunders, R. M. Wainess, J. B. Dimick et al., “Who performs endocrine operations in the United States?” Surgery, vol. 134, no. 6, pp. 924–931, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Sosa, H. M. Bowman, J. M. Tielsch, N. R. Powe, T. A. Gordon, and R. Udelsman, “The importance of surgeon experience for clinical and economic outcomes from thyroidectomy,” Annals of Surgery, vol. 228, no. 3, pp. 320–330, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. I. D. Hay, C. S. Grant, E. J. Bergstralh et al., “Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?” Surgery, vol. 124, no. 6, pp. 958–966, 1998. View at Google Scholar · View at Scopus
  23. O. H. Clark, “Total thyroidectomy. The treatment of choice for patients with differentiated thyroid cancer,” Annals of Surgery, vol. 196, no. 3, pp. 361–370, 1982. View at Google Scholar · View at Scopus
  24. H. D. Röher and P. E. Goretzki, “Management of goiter and thyroid nodules in an area of endemic goiter,” Surgical Clinics of North America, vol. 67, no. 2, pp. 233–249, 1987. View at Google Scholar · View at Scopus
  25. S. F. Leung, M. W. M. Law, and S. K. W. Ho, “Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases,” British Journal of Radiology, vol. 65, no. 778, pp. 905–909, 1992. View at Google Scholar · View at Scopus
  26. J. N. Attie, G. W. Moskowitz, D. Margouleff, and L. M. Levy, “Feasibility of total thyroidectomy in the treatment of thyroid carcinoma. Postoperative radioactive iodine evaluation of 140 cases,” American Journal of Surgery, vol. 138, no. 4, pp. 555–560, 1979. View at Google Scholar · View at Scopus
  27. A. M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman, and H. C. Gerstein, “A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3668–3676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Gharib, E. Papini, R. Valcavi et al., “American association of clinical endocrinologists and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules,” Endocrine Practice, vol. 12, no. 1, pp. 63–102, 2006. View at Google Scholar · View at Scopus
  29. R. S. Sippel and H. Chen, “Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer,” Thyroid, vol. 19, no. 12, pp. 1373–1380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Schlumberger, F. Mancusi, E. Baudin, and F. Pacini, “131I therapy for elevated thyroglobulin levels,” Thyroid, vol. 7, no. 2, pp. 273–276, 1997. View at Google Scholar
  31. D. van Nostrand and L. Wartofsky, “Radioiodine in the treatment of thyroid cancer,” Endocrinology and Metabolism Clinics of North America, vol. 36, no. 3, pp. 807–822, , vii-viii, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Erbil, U. Barbaros, A. Salmaslioglu et al., “Determination of remnant thyroid volume: comparison of ultrasonography, radioactive iodine uptake and serum thyroid-stimulating hormone level,” Journal of Laryngology and Otology, vol. 122, no. 6, pp. 615–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. F. Schneider, K. A. Ojomo, H. Chen, and R. S. Sippel, “Remnant uptake as a postoperative oncologic quality indicator,” Thyroid, vol. 23, no. 10, pp. 1269–1276, 2013. View at Google Scholar
  34. S. C. Oltmann, D. F. Schneider, G. Leverson, T. Sivashanmugam, H. Chen, and R. S. Sippel, “Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation,” Annals of Surgical Oncology, vol. 21, no. 4, pp. 1379–1383, 2013. View at Google Scholar
  35. E. G. Grubbs and D. B. Evans, “Role of lymph node dissection in primary surgery for thyroid cancer,” Journal of the National Comprehensive Cancer Network, vol. 5, no. 6, pp. 623–630, 2007. View at Google Scholar · View at Scopus
  36. S. Noguchi, A. Noguchi, and N. Murakami, “Papillary carcinoma of the thyroid: developing pattern of metastasis,” Cancer, vol. 26, no. 5, pp. 1053–1060, 1970. View at Google Scholar · View at Scopus
  37. S. W. Qubain, S. Nakano, M. Baba, S. Takao, and T. Aikou, “Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma,” Surgery, vol. 131, no. 3, pp. 249–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Arturi, D. Russo, D. Giuffrida et al., “Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes,” The Journal of Clinical Endocrinology and Metabolism, vol. 82, pp. 1638–1641, 1997. View at Google Scholar
  39. N. Wada, Q. Duh, K. Sugino et al., “Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection,” Annals of Surgery, vol. 237, no. 3, pp. 399–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Wada, N. Suganuma, H. Nakayama et al., “Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes,” Langenbeck's Archives of Surgery, vol. 392, no. 4, pp. 417–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. D. Podnos, D. Smith, L. D. Wagman, and J. D. I. Ellenhorn, “The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer,” American Surgeon, vol. 71, no. 9, pp. 731–734, 2005. View at Google Scholar · View at Scopus
  42. V. Zaydfudim, I. D. Feurer, M. R. Griffin, and J. E. Phay, “The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma,” Surgery, vol. 144, no. 6, pp. 1070–1078, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Cady, R. Rossi, I. Hay, K. H. Cohn, and N. W. Thompson, “An expanded view of risk-group definition in differentiated thyroid carcinoma,” Surgery, vol. 104, no. 6, pp. 947–953, 1988. View at Google Scholar · View at Scopus
  44. S. B. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, and A. Trotti, AJCC Cancer Staging Atlas, Springer, New York, NY, USA, 2010.
  45. I. D. Hay, C. S. Grant, W. F. Taylor, and W. M. McConahey, “Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system,” Surgery, vol. 102, no. 6, pp. 1088–1095, 1987. View at Google Scholar · View at Scopus
  46. D. P. Byar, S. B. Green, and P. Dor, “A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group,” European Journal of Cancer and Clinical Oncology, vol. 15, no. 8, pp. 1033–1041, 1979. View at Google Scholar · View at Scopus
  47. S. I. Sherman, J. D. Brierley, M. Sperling et al., “Prospective multicenter study of thyroid carcinoma treatment,” Cancer, vol. 83, pp. 1012–1021, 1988. View at Google Scholar
  48. E. L. Mazzaferri and S. M. Jhiang, “Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer,” American Journal of Medicine, vol. 97, no. 5, pp. 418–428, 1994. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Sywak, L. Cornford, P. Roach, P. Stalberg, S. Sidhu, and L. Delbridge, “Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer,” Surgery, vol. 140, no. 6, pp. 1000–1007, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. D. T. Hughes, M. L. White, B. S. Miller, P. G. Gauger, R. E. Burney, and G. M. Doherty, “Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer,” Surgery, vol. 148, no. 6, pp. 1100–1106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. L. E. Tisell, B. Nilsson, J. Molne et al., “Improved survival of patients with papillary thyroid cancer after surgical microdissection,” World Journal of Surgery, vol. 20, pp. 854–859, 1996. View at Google Scholar
  52. B. H. Lang, K. P. Wong, K. Y. Wan, and C. Y. Lo, “Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection,” Annals of Surgical Oncology, vol. 19, pp. 1257–1263, 2012. View at Google Scholar
  53. E. L. Mazzaferri, G. M. Doherty, and D. L. Steward, “The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma,” Thyroid, vol. 19, no. 7, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Mocellin, S. Pasquali, C. Riccardo Rossi, and D. Nitti, “Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases,” Surgery, vol. 150, no. 1, pp. 83–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. C. Schiffman, K. M. McMasters, C. R. Scoggins, R. C. Martin, and A. B. Chagpar, “Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients,” Journal of the American College of Surgeons, vol. 213, no. 1, pp. 45–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. D. F. Schneider, H. Chen, and R. S. Sippel, “The impact of lymph node ratio on survival in papillary thyroid cancer,” Annals of Surgical Oncology, vol. 20, pp. 1906–1911, 2013. View at Google Scholar
  57. D. F. Schneider, H. Mazeh, H. Chen, and R. S. Sippel, “Lymph node ratio predicts recurrence in papillary thyroid cancer,” The Onocoligist, vol. 18, pp. 157–162, 2013. View at Google Scholar